Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
Patrys Limited ( (AU:PAB) ) has provided an announcement.
Patrys Limited has announced a change in its registered office and principal place of business to a new address in Melbourne, Australia. This move aligns with the company’s ongoing commitment to developing its innovative deoxymab platform, which has shown promise in targeting cancer cells and addressing inflammatory diseases, potentially transforming treatment landscapes.
More about Patrys Limited
Based in Melbourne, Australia, Patrys Limited is a therapeutic antibody development company focused on its deoxymab platform. These cell-penetrating antibodies target cancer cells by binding to DNA fragments released during cell death, offering potential treatments for various cancers and inflammatory diseases.
Technical Sentiment Signal: Strong Sell
Current Market Cap: A$3.09M
See more data about PAB stock on TipRanks’ Stock Analysis page.
Trending Articles:
Looking for a trading platform? Check out TipRanks' Best Online Brokers , and find the ideal broker for your trades.
Report an Issue